Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
Phase 2
Active, not recruiting
- Conditions
- Subcutaneous Fat Disorder
- Interventions
- Drug: 10XB-101 Solution for Injection, 6.0%Drug: Placebo Solution for Injection (no active ingredient)
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- 10xBio, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT05760248
- Locations
- ๐บ๐ธ
Site #01, Rolling Meadows, Illinois, United States
๐บ๐ธSite #02, New Brighton, Minnesota, United States
A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat
Phase 2
Active, not recruiting
- Conditions
- Submental Fat
- Interventions
- Drug: 10XB-101 Vehicle Solution for InjectionDrug: 10XB-101 Solution for Injection
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- 10xBio, LLC
- Target Recruit Count
- 52
- Registration Number
- NCT05154955
- Locations
- ๐บ๐ธ
Site 01, San Diego, California, United States
๐บ๐ธSite 04, Rolling Meadows, Illinois, United States
๐บ๐ธSite 03, Encino, California, United States
A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")
Phase 2
Completed
- Conditions
- Submental Fat
- Interventions
- Drug: 10XB-101 Solution for Injection
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- 10xBio, LLC
- Target Recruit Count
- 15
- Registration Number
- NCT04258761
- Locations
- ๐บ๐ธ
Site 01, San Diego, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath